Close Menu

NEW YORK – The US Food and Drug Administration announced late Wednesday that it has authorized the first antibody assay intended for use at the point of care to detect previous SARS-CoV-2 infection. The Assure COVID-19 IgG/IgM Rapid Test Device, which is manufactured by Hangzhou, China-based Assure Tech, is for use on finger-stick blood samples.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.